ArticleExperimental biology and medicine (Maywood, N.J.)2017

Original Research: Featured Article: Imatinib mesylate (Gleevec) inhibits Notch and c-Myc signaling: Five-day treatment permanently rescues mammary development.

Robert Callahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.